Theodore Kremer
Pediatrics · Hazelwood, MONPI 1013397751
Payments from drug & device makers
What this record shows
39 manufacturers reported payments, led by Sanofi Pasteur Inc. at 26.1% of the total. Reporting peaked in 2023 at $2,273 and has fallen 92.0% since, to $181 in 2024. Among pediatrics clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 140 payments — averaging $38.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi Pasteur Inc.$1K
- AbbVie$1K
- GSK$401
- Corium, LLC$313
- Tris Pharma Inc$278
- AstraZeneca$158
- plus $2K from 33 others
What the payments were for
- Consulting fees$2,43645%
- Food & beverage$2,99855%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi Pasteur Inc. | 10 | $1,417 |
| AbbVie | 7 | $1,331 |
| GSK | 16 | $401 |
| Corium, LLC | 12 | $313 |
| Tris Pharma Inc | 13 | $278 |
| AstraZeneca(2 entities) | 3 | $158 |
| Sobi, Inc | 3 | $138 |
| Dexcom, Inc. | 5 | $110 |
| Dermira, Inc. | 1 | $100 |
| Cranial Technologies, Inc | 5 | $87 |
| Amgen | 4 | $80 |
| Ascendis Pharma Endocrinology Inc | 4 | $79 |
| Boehringer Ingelheim | 5 | $77 |
| Tolmar, Inc. | 3 | $67 |
| Pfizer | 4 | $65 |
| Novo Nordisk | 4 | $63 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $59 |
| Merck | 4 | $53 |
| Ironshore Pharmaceuticals Inc. | 3 | $48 |
| Intuity Medical Inc | 2 | $45 |
| Kyowa Kirin, Inc. | 2 | $44 |
| Lilly USA, LLC | 3 | $43 |
| Xeris Pharmaceuticals, Inc. | 2 | $37 |
| Grifols USA, LLC | 2 | $35 |
| Neurelis, Inc. | 2 | $35 |
| Tolmar Pharmaceuticals, Inc. | 2 | $32 |
| Amarin Pharma, Inc. | 2 | $26 |
| Kaleo, Inc. | 2 | $25 |
| Almatica Pharma LLC | 1 | $24 |
| Endo Pharmaceuticals Inc. | 1 | $22 |
| Medtronic | 1 | $21 |
| Zealand Pharma US, Inc. | 1 | $18 |
| Azurity Pharmaceuticals, Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Ultragenyx Pharmaceutical Inc. | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| Neos Therapeutics, LP | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lupron Depot$1,200
- BREZTRI$123
- Azstarys$122
- Dyanavel XR$120
- BEXSERO$109
- QBREXZA$100
How this compares
$5,434 in reported general payments places this provider in the 95th percentile of 1,306 pediatrics providers in Missouri.
Other pediatrics in Hazelwood
- John GalganiHazelwood$18K
- Richard KnightHazelwood$4K
- Jeong Kim-JuddHazelwood$4K
- Seth BrownridgeHazelwood$3K
- Earline BrownridgeHazelwood$3K
- Molly FiggemeierSaint Louis$74K
- Terri LuetjenKansas City$57K
- Alexander FaySaint Louis$53K
- Kevin MurphyFlorissant$52K
- Sharon HumistonKansas City$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.